Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2005
12/08/2005WO2005047526A3 Method for identifying inhibitors using a homology model of polo-like kinase 1
12/08/2005WO2005047471A3 Improved fret efficiency methods
12/08/2005WO2005026389A3 Ligation-based method of analysis of single nucleotide polymorphisms on genomic dna
12/08/2005WO2005026378B1 Methods for gene function analysis
12/08/2005WO2005025409A3 Methods for risk assessment, survival prediction and treatment of heart failure and other conditions based on adrenergic receptor polymorphisms
12/08/2005WO2005021784A3 Estimation of activity or inhibition of processes involved in nucleic acid modification using chemiluminescence quenching
12/08/2005WO2005019410A3 Rnai agents for anti-sars coronavirus therapy
12/08/2005WO2004113554A3 Methods for determining susceptibility to psoriasis
12/08/2005WO2004082617A3 Biological markers for diagnosing rheumatoid arthritis
12/08/2005WO2004066948A3 Mapcaxs as modifiers of the apc and axin pathways and methods of use
12/08/2005WO2004058042A3 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
12/08/2005WO2004050895A3 Methods and compositions for inducing apoptosis in cancer cells
12/08/2005WO2004045522A3 Absolute quantitation of nucleic acids by rt-pcr
12/08/2005WO2004005468A3 Axs gene and protein and methods related thereto
12/08/2005WO2003060148A3 Androgen regulated nucleic acid molecules and encoded proteins
12/08/2005WO2002066494A3 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
12/08/2005US20050273884 PUFA polyketide synthase systems and uses thereof
12/08/2005US20050273883 Pufa polyketide synthase systems and uses thereof
12/08/2005US20050273871 Method for diagnosing arrhythmogenic right ventricular dysplasia
12/08/2005US20050273868 Methods and compositions for enhancing RISC activity in vitro and in vivo
12/08/2005US20050273275 Method and system for profiling biological systems
12/08/2005US20050273271 Method of characterizing cell shape
12/08/2005US20050273270 Profile searching in nucleic acid sequences using the fast fourier transformation
12/08/2005US20050273267 Method for identifying markers
12/08/2005US20050272989 Analyte sensors and methods for making and using them
12/08/2005US20050272924 Invention provides a DNA molecule capable of expressing a heterologous polypeptide under cold shock conditions, where the DNA molecule is preferably a self-replicating expression vector
12/08/2005US20050272923 Mature microRNA prediction method using bidirectional hidden markov model and medium recording computer program to implement the same
12/08/2005US20050272796 Prevention and treatment of benign prostatic hyperplasia using lonidamine and lonidamine analogs
12/08/2005US20050272795 Prevention and treatment of benign prostatic hyperplasia
12/08/2005US20050272684 Breast cancer resistance protein (BCRP) and the DNA which encodes it
12/08/2005US20050272681 Ribosome structure and protein synthesis inhibitors
12/08/2005US20050272679 Contains modified ribose rings within RNA; solid phase synthesis; kits
12/08/2005US20050272658 Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP)
12/08/2005US20050272362 Genetic test for PSE-susceptible turkeys
12/08/2005US20050272157 Method of evaluating freshness of a fish product
12/08/2005US20050272155 Methods and compositions for enhancing cell adhesion properties
12/08/2005US20050272119 Polypeptides having 2',5'-oligoadenylate phosphodiesterase activity, antibodies against polypeptides, polynucleotides coding for polypeptides, recombinant plasmid DNAs into which polynucleotides have been inserted; for searching for antitumor agents, viricides
12/08/2005US20050272117 Method
12/08/2005US20050272115 Examination of harmful bacterium in food or drink
12/08/2005US20050272114 wherein mutant hydrolase forms stable bond with rhodococcus dehalogenase substrate; beta-lactamases; fustion proteins; cell labelling; tissue target therapy
12/08/2005US20050272113 Saliva test for hemolytic streptococcus
12/08/2005US20050272112 Direct assay of cholesterol in skin removed by tape stripping
12/08/2005US20050272105 Bacterial biosensors
12/08/2005US20050272100 Separation and quantification of biotinylated macromolecules
12/08/2005US20050272092 Novel gene having reverse transcriptas motif
12/08/2005US20050272091 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection
12/08/2005US20050272090 Nucleic acid binding of multi-zinc finger transcription factors
12/08/2005US20050272089 Critical genes and polypeptides of haemophilus influenzae and methods of use
12/08/2005US20050272087 Apparatus and method for finding genes associated with diseases
12/08/2005US20050272086 Methods for genomic analysis
12/08/2005US20050272085 Methods for forensic and congenic screening
12/08/2005US20050272084 Suitable for use in bioassays to be carried out in biological fluids absorbing radiation in the wavelength range 300 to 600 nm, especially whole blood, serum or plasma; measurement of analyte concentration or biological activity in biological fluid, only weakly transparent or non-transparent
12/08/2005US20050272083 EGFR mutations
12/08/2005US20050272082 Alternatively spliced isoform of acetyl-CoA carboxylase 2 (ACC2)
12/08/2005US20050272081 Methods, compositions and apparatus for making nucleic acid molecules having a selected affinity to a target molecule
12/08/2005US20050272080 Methods of analysis of degraded nucleic acid samples
12/08/2005US20050272079 Thermal microvalves
12/08/2005US20050272078 Peptic nucleic acid probes for analysis of Enterococcus faecium
12/08/2005US20050272077 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
12/08/2005US20050272075 Novel methods for quantification of microRNAs and small interfering RNAs
12/08/2005US20050272074 Compositions and methods for reverse transcription
12/08/2005US20050272073 Ploidy classification method
12/08/2005US20050272072 Ligand-dependent protein splicing
12/08/2005US20050272071 Encoding and decoding reactions for determining target polynucleotides
12/08/2005US20050272070 Base specific cleavage of methylation-specific amplification products in combination with mass analysis
12/08/2005US20050272068 UCH-L1 expression and cancer therapy
12/08/2005US20050272067 Compositions, splice variants and methods relating to cancer specific genes and proteins
12/08/2005US20050272066 Using f-box containing protein as tool in treatment and prevention of infection, cardiovascular, cell proliferative and nervous system disorders
12/08/2005US20050272065 Differential enzymatic fragmentation by whole genome amplification
12/08/2005US20050272064 Enzymatic polypeptide comprising halogenase activity for use in production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters; bioremediation; pollution control
12/08/2005US20050272063 Method for treating synovial sarcoma
12/08/2005US20050272062 Bacteria detecting instrument, bacteria detecting method, and bacteria detecting kit
12/08/2005US20050272061 Expression profiling in non-small cell lung cancer
12/08/2005US20050272060 Chimeric CrylE delta endotoxin and methods of controlling insects
12/08/2005US20050272059 Method for providing microarrays
12/08/2005US20050272058 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/08/2005US20050272057 Small segments of DNA determine animal identity and source
12/08/2005US20050272056 Gene identification method
12/08/2005US20050272055 Method of treating lethal shock induced by toxic agents and diagnosing exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes
12/08/2005US20050272054 detecting specific single nucleotide polymorphisms (SNPs) in the human genome, and their association with acute coronary events and/or variability in the responsiveness to statin treatment (including preventive treatment) between different individuals; assessing for risk of heart disease
12/08/2005US20050272053 Oligonucleotides labeled with a plurality of fluorophores
12/08/2005US20050272052 Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer
12/08/2005US20050272051 Methods of preventing or treating recurrence of myocardial infarction
12/08/2005US20050272050 Receptor protein for identifying modulators to treat and prevent inflammatory, antherosclerotic and cancer disorders; wound healing agents
12/08/2005US20050272049 Arrays of magnetic particles
12/08/2005US20050272048 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
12/08/2005US20050272046 Methods, apparatus and compositions for improved measurements with optical biosensors
12/08/2005US20050272045 Anti-Hpr6 agents, to enhance the killing effect of anti-cancer agents in non-sarcoma tumor cells and to teat non-sarcoma tumors
12/08/2005US20050272044 Method and kit for the detection and/or quantification of homologous nucleotide sequences on arrays
12/08/2005US20050272043 Using allelic variation in cellular adhesion and map kinase gene sequences as diagnostic tools in detection of mammary gland cell proliferative disorders
12/08/2005US20050272042 preselecting via computational techniques; high speed hybridization; bioinformatics
12/08/2005US20050272041 isolated polynucleotide encoding Enzymatic proteins for use in food processing, paper making and recycling
12/08/2005US20050272040 Method for increasing synaptic growth or plasticity
12/08/2005US20050272035 Functional screening method
12/08/2005US20050272034 Methods of detecting ovarian neoplasia
12/08/2005US20050272033 detecting wheat allergen, by perform polymerase chain reaction on food DNA extracts; food analysis
12/08/2005US20050272032 Internal control for in situ hybridization
12/08/2005US20050272031 Viral variants and uses therefor
12/08/2005US20050272030 Nucleic acid constructs for gene expression
12/08/2005US20050272029 Hepatitis c viral-like particle purification